(Q22305432)

21 June 2017

title

Advances and hurdles on the way toward a leprosy vaccine (English)

1 reference

21 June 2017

0 references

3

Steven G Reed

Steven G

Reed

1 reference

21 June 2017

Malcolm S Duthie

1

Malcolm S

Duthie

1 reference

21 June 2017

Thomas P Gillis

series ordinal

2

author given names

Thomas P

author last names

Gillis

1 reference

21 June 2017

language of work or name

English

0 references

publication date

1 November 2011

1 reference

21 June 2017

1 reference

21 June 2017

volume

7

1 reference

21 June 2017

issue

11

1 reference

21 June 2017

page(s)

1172-1183

1 reference

The continuing challenges of leprosy

21 June 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

BCG vaccination and leprosy protection: review of current evidence and status of BCG in leprosy control

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Massive gene decay in the leprosy bacillus

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Enumeration of Mycobacterium leprae using real-time PCR

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Comparative genomics of BCG vaccines by whole-genome DNA microarray

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Increased CXC ligand 10 levels and gene expression in type 1 leprosy reactions

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Immunologically reactive M. leprae antigens with relevance to diagnosis and vaccine development

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Integration of leprosy elimination into primary health care in orissa, India

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Vaccination with the ML0276 antigen reduces local inflammation but not bacterial burden during experimental Mycobacterium leprae infection

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Inhibition of the multiplication of Mycobacterium leprae by vaccination with a recombinant M. bovis BCG strain that secretes major membrane protein II in mice

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Disseminated bacille Calmette-Guérin disease in HIV-infected South African infants

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Potential plasma markers of Type 1 and Type 2 leprosy reactions: a preliminary report

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Biomarkers for tuberculosis disease activity, cure, and relapse

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Antigen-specific T-cell responses of leprosy patients

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Tuberculosis in Africa: learning from pathogenesis for biomarker identification

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Biomarkers for TB treatment response: challenges and future strategies

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Expression and characterization of recombinant interferon gamma (IFN-gamma) from the nine-banded armadillo (Dasypus novemcinctus) and its effect on Mycobacterium leprae-infected macrophages.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Noncompliance with the world health organization-multidrug therapy among leprosy patients in Cebu, Philippines: its causes and implications on the leprosy control program.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

The frequency of drug resistance mutations in Mycobacterium leprae isolates in untreated and relapsed leprosy patients from Myanmar, Indonesia and the Philippines.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

The prevalence of previously undiagnosed leprosy in the general population of northwest bangladesh

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

BCG revaccination does not protect against leprosy in the Brazilian Amazon: a cluster randomised trial

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Advances in the treatment of reactions in leprosy.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Risk and protective factors for leprosy development determined by epidemiological surveillance of household contacts

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Use of protein antigens for early serological diagnosis of leprosy

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Long lasting BCG protection against leprosy

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Antigen-specific cellular and humoral responses are induced by intradermal Mycobacterium leprae infection of the mouse ear.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Biomarkers of treatment response in clinical trials of novel antituberculosis agents

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Immunostimulatory activity of recombinant Mycobacterium bovis BCG that secretes major membrane protein II of Mycobacterium leprae

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Mycobacterium leprae is naturally resistant to PA-824

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

BCG vaccine: efficacy and indications for vaccination and revaccination

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Risk factors for developing leprosy--a population-based cohort study in Indonesia.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Delay in the diagnosis of leprosy in the Metropolitan Region of Vitória, Brazil.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

The role of BCG in prevention of leprosy: a meta-analysis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Identification of an Immunomodulating Agent from Mycobacterium leprae

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Prevention of leprosy using rifampicin as chemoprophylaxis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Leprosy: too complex a disease for a simple elimination paradigm

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Antigenic trigger for type 1 reaction in leprosy

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

IFN-gamma-inducible protein 10 and pentraxin 3 plasma levels are tools for monitoring inflammation and disease activity in Mycobacterium tuberculosis infection

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

The future incidence of leprosy: a scenario analysis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Molecular detection of drug resistance in Mycobacterium leprae

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Trends in leprosy case detection worldwide since 1985.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Effect of vaccination with refined components of the organism on infection of mice with Mycobacterium leprae

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Epidemiology of leprosy on five isolated islands in the Flores Sea, Indonesia

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Multidrug resistant Mycobacterium leprae from patients with leprosy.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

The diagnosis of leprosy is delayed in the United Kingdom

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Endothelial cells and the pathogenesis of lepromatous neuritis:insights from the armadillo model

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Detection of phenolic glycolipid I of Mycobacterium leprae in sera from leprosy patients before and after start of multidrug therapy

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Chemoprophylaxis is effective in the prevention of leprosy in endemic countries: a systematic review and meta-analysis. MILEP2 Study Group. Mucosal Immunology of Leprosy

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Protective effect of Bacillus Calmette Guerin (BCG) against leprosy: a population-based case-control study in Nagpur, India

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

High relapse rate among lepromatous leprosy patients treated with rifampin plus ofloxacin daily for 4 weeks.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Some factors influencing delay in leprosy diagnosis.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Clinical trial of ofloxacin alone and in combination with dapsone plus clofazimine for treatment of lepromatous leprosy

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Vaccination with pure Mycobacterium leprae proteins inhibits M. leprae multiplication in mouse footpads

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Chemotherapy of lepromatous leprosy: recent developments and prospects for the future

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Searches among mycobacterial cultures for antileprosy vaccines

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Comparison of the immunogenicity of vaccines prepared from viable Mycobacterium bovis BCG, heat-killed Mycobacterium leprae, and a mixture of the two for normal and M. leprae-tolerant mice

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Classification of leprosy according to immunity. A five-group system

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Vaccination of mice against Mycobacterium leprae infection

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Effective vaccination of mice against leprosy bacilli with subunits of Mycobacterium leprae

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

The systemic influence of recombinant interleukin 2 on the manifestations of lepromatous leprosy

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Ofloxacin for the treatment of leprosy.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Prolonged treatment with recombinant interferon gamma induces erythema nodosum leprosum in lepromatous leprosy patients

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

A vaccine from ICRC bacilli against M. leprae infection in mouse foot-pad

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Effect of cyclosporine A in erythema nodosum leprosum

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

THE EXPERIMENTAL DISEASE THAT FOLLOWS THE INJECTION OF HUMAN LEPROSY BACILLI INTO FOOT-PADS OF MICE.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Studies on risk of leprosy relapses in China: relapses after treatment with dapsone monotherapy.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Self-healing leprosy: report on 2749 patients.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

PGL-I antigen and antibody detection in leprosy patients: evolution under chemotherapy

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Study of 39 documented relapses of multibacillary leprosy after treatment with rifampin.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Immunotherapeutic effects of a vaccine based on a saprophytic cultivable mycobacterium, Mycobacterium w in multibacillary leprosy patients

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Sequential monitoring of leprosy patients with serum antibody levels to phenolic glycolipid-I, a synthetic analog of phenolic glycolipid-I, and mycobacterial lipoarabinomannan.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Efficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Immunoprophylactic trial with combined Mycobacterium leprae/BCG vaccine against leprosy: preliminary results

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Physical distance, genetic relationship, age, and leprosy classification are independent risk factors for leprosy in contacts of patients with leprosy

30 May 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.16848

Long-term efficacy of 2 year WHO multiple drug therapy (MDT) in multibacillary (MB) leprosy patients

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.16848

Relapses in multibacillary patients treated with multi-drug therapy until smear negativity: findings after twenty years

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.16848

Molecular detection of rifampin and ofloxacin resistance for patients who experience relapse of multibacillary leprosy

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.16848

A Second Case of Multidrug-resistant Mycobacterium leprae Isolated from a Japanese Patient with Relapsed Lepromatous Leprosy

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.16848

Mutations in genes related to drug resistance in Mycobacterium leprae isolates from leprosy patients in Korea.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.16848

Effectiveness of BCG vaccination among leprosy contacts: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.16848

Immunostimulatory activity of major membrane protein-II from Mycobacterium leprae.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.16848

The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.16848

Bacillus Calmette-Guérin (BCG) vaccine-induced complications in children treated with highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.16848

Expression of nine-banded armadillo (Dasypus novemcinctus) interleukin-2 in E. coli

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.16848

10-12 years follow-up of highly bacillated BL/LL leprosy patients on combined chemotherapy and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.16848

Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.16848

Interferon-gamma responses after isoniazid chemotherapy for latent tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.16848

Dynamic Antigen-specific T-Cell Responses after Point-Source Exposure toMycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.16848

Changes in the kinetics of intracellular IFN-gamma production in TB patients during treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.16848

The relationship between detection delay and impairment in leprosy control: a comparison of patient cohorts from Bangladesh and Ethiopia.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Delay in presentation, an indicator for nerve function status at registration and for treatment outcome--the experience of the Bangladesh Acute Nerve Damage Study cohort

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Vaccination with DNA of the Mycobacterium tuberculosis 85B antigen protects mouse foot pad against infection with M. leprae.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Effects of vaccination with several mycobacterial proteins and lipoproteins on Mycobacterium leprae infection of the mouse.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Estimating hidden prevalence in Hansen's disease through diagnosis delay and grade of disability at time of diagnosis.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

A Mycobacterium leprae isolate resistant to dapsone, rifampin, ofloxacin and sparfloxacin.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Dapsone drug resistance in the MDT era.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Studies on risk of leprosy relapses in China: relapses after treatment with multidrug therapy.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Serological monitoring of the response to chemotherapy in leprosy patients.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Effects of chemotherapy on antibody levels directed against PGL-I and 85A and 85B protein antigens in lepromatous patients

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Activity of combinations of dapsone, rifampin, minocycline, clarithromycin, and sparfloxacin against M. leprae-infected mice

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323495

Induction of lepromin positivity in monkeys by a candidate antileprosy vaccine: Mycobacterium habana

29 November 2018

1 reference

12 December 2020

Vaccination against leprosy at Ben San Leprosy Centre, Ho Chi Minh City, Vietnam

1 reference

12 December 2020

Comparative evaluation of immunotherapeutic efficacy of BCG and mw vaccines in patients of borderline lepromatous and lepromatous leprosy

1 reference

12 December 2020

Evaluation of phenolic glycolipid-I (PGL-I) antibody as a multidrug therapy (MDT) monitor

1 reference

12 December 2020

Antibodies to phenolic glycolipid-I during long-term therapy: serial measurements in individual patients

1 reference

12 December 2020

Leprosy chemoprophylaxis in Micronesia

1 reference

12 December 2020

Self-healing in non-lepromatous leprosy in the area of the ELEP Leprosy Control Project Dharmapuri (Tamil Nadu)

1 reference

12 December 2020

Immunoprophylaxis against Mycobacterium leprae infection with subunit vaccines

1 reference

12 December 2020

Global leprosy situation, 2005

1 reference

12 December 2020

Comparative leprosy vaccine trial in south India

1 reference

12 December 2020

Inhibition of multiplication of Mycobacterium leprae in mouse foot pads by immunization with ribosomal fraction and culture filtrate from Mycobacterium bovis BCG

1 reference

12 December 2020

Combination of rifapentine-moxifloxacin-minocycline (PMM) for the treatment of leprosy

1 reference

12 December 2020

Global leprosy situation, 2010

1 reference

12 December 2020

Chemoprophylaxis of leprosy in the southern Marquesas with a single 25 mg/kg dose of rifampicin. Results after 10 years

1 reference

12 December 2020

Inhibition of multiplication of Mycobacterium leprae in mouse foot pads by recombinant Bacillus Catmette-Guérin (BCG)

1 reference

12 December 2020

Effect of hsp65 DNA vaccination carrying immunostimulatory DNA sequences (CpG motifs) against Mycobacterium leprae multiplication in mice

1 reference

12 December 2020

Classification of leprosy: a full color spectrum, or black and white?

1 reference

12 December 2020

Relapses in multibacillary leprosy patients: effect of length of therapy

1 reference

12 December 2020

Global tuberculosis programme and global programme on vaccines. Statement on BCG revaccination for the prevention of tuberculosis

1 reference

12 December 2020

Global leprosy situation, 2007

1 reference

12 December 2020

The antigen 85 complex vaccine against experimental Mycobacterium leprae infection in mice

1 reference

12 December 2020

Armadillos (Dasypus novemcinctus) as a model to test antileprosy vaccines; a preliminary report

1 reference

12 December 2020

A comparison of Rapid Village Survey and Leprosy Elimination Campaign, detection methods in two districts of East Java, Indonesia, 1997/1998 and 1999/2000

1 reference

12 December 2020

Serum beta-glucuronidase levels in children with leprosy

1 reference

12 December 2020

Serological markers of pulmonary tuberculosis and of response to anti-tuberculosis treatment in a patient population in Guinea

1 reference

12 December 2020

Protective responses against experimental Mycobacterium leprae infection in mice induced by recombinant Bacillus Calmette-Guérin over-producing three putative protective antigen candidates

1 reference

12 December 2020

Efficacy of minocycline in single dose and at 100 mg twice daily for lepromatous leprosy

1 reference

12 December 2020

Global leprosy situation, 2009

1 reference

12 December 2020

Evaluation of the efficacy of candidate vaccines against M. leprae infection in mice

1 reference

12 December 2020

Leprosy in China: delay in the detection of cases

1 reference

12 December 2020

Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Karonga Prevention Trial Group

1 reference

12 December 2020

Clofazimine and dapsone compliance in leprosy

1 reference

12 December 2020

A follow-up study of multibacillary Hansen's disease patients treated with multidrug therapy (MDT) or MDT + immunotherapy (IMT)

1 reference

12 December 2020

The relapse rate in MB leprosy patients treated with 2-years of WHO-MDT is not low

1 reference

12 December 2020

Combined multidrug and Mycobacterium w vaccine therapy in patients with multibacillary leprosy

1 reference

12 December 2020

Specific IgG antibody responses may be used to monitor leprosy treatment efficacy and as recurrence prognostic markers

1 reference

12 December 2020

Response of Mycobacterium habana vaccine in patients with lepromatous leprosy and their household contacts. A pilot clinical study

1 reference

12 December 2020

Effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of leprosy: a population-based case-control study in Yavatmal District, India

1 reference

12 December 2020

Infection of distal peripheral nerves by M. leprae in infected armadillos; an experimental model of nerve involvement in leprosy

1 reference

12 December 2020

Cyclosporin A is not very effective in erythema nodosum leprosum (ENL)

1 reference

12 December 2020

Immunoprophylactic effects of the anti-leprosy Mw vaccine in household contacts of leprosy patients: clinical field trials with a follow up of 8-10 years

1 reference

12 December 2020

Identifiers

DOI

10.4161/HV.7.11.16848

1 reference

release_grzcflhlzjekvnfkdbqigxox2y

21 June 2017

Fatcat ID

0 references

PMC publication ID

3323495

0 references

1 reference